Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
Order by:
- [r.170] The road to better urticaria and angioedema management (5)
- [r.169] Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema (3)
- [o.417] Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy (0)
- [r.168] Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy? (0)
- [o.405] Articular angioedema in patients with chronic spontaneous urticaria is frequently misdiagnosed as arthritis (0)
- [o.401] Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results (1)
- [o.400] Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study (4)
- [o.388] Validation of the angioedema control test (AECT) – a patient reported outcome instrument for assessing angioedema control (8)
- [o.387] Development of the angioedema control test (AECT) – a patient reported outcome measure that assesses disease control in patients with recurrent angioedema (4)
- [r.158] Urticaria: Collegium Internationale Allergologicum (CIA) update 2020 (11)
- [bc.32] Urticaria (3)
- [o.229] Rupatadine in established treatment schemes improves chronic spontaneous urticaria symptoms and patients’ quality of life: a prospective, non-interventional trial (0)
- [o.258] Definition, aims, and implementation of GA²LEN urticaria centers of reference and excellence (3)
- [o.261] Effect of omalizumab on angioedema in H1-antihistamine resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (3)
- [o.262] The angioedema quality of life questionnaire (AE-QoL) – assessment of sensitivity to change and minimal clinically important difference (8)
- [o.219] ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria (1)
- [o.273] Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice (0)
- [o.274] H1-antihistamine-refractory chronic spontaneous urticaria: It’s worse than we thought – first results of the multicenter real-life AWARE study (3)
- [o.285] The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU (2)
- [o.298] Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data (2)
(Last update: 07.2025)
| Number of original publications in peer-reviewed journals: | 650 |
| Number of reviews in peer-reviewed journals: | 229 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 879 |
| Cumulative IF for original publications in peer-reviewed journals: | 4648.29 |
| Cumulative IF for reviews in peer-reviewed journals: | 1689.22 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 6761.91 |
| Total number of citations: 45.522, h-index: 109 (Web of Science Juli 2025) | 45522 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.